ATYR Performance & Benchmarks - 141% in 12m

The Total Return for 3m is 40.7%, for 6m 31.7% and YTD 29.8%. Compare with Peer-Group: Biotechnology

Performance Rating 6.68%
#29 in Peer-Group
Rel. Strength 96.15%
#297 in Stock-Universe
Total Return 12m 141.03%
#11 in Peer-Group
Total Return 5y 20.51%
#30 in Peer-Group
P/E Value
P/E Trailing -
P/E Forward -
High / Low USD
52 Week High 6.61 USD
52 Week Low 1.72 USD
Sentiment Value
VRO Trend Strength +-100 8.57
Buy/Sell Signal +-5 1.05
Support / Resistance Levels
Support
Resistance
12m Total Return: ATYR (141%) vs XBI (-12.9%)
Total Return of aTyr Pharma versus its related sector ETF XBI
5y Drawdown (Underwater) Chart
5 Year Drawdown / Underwater Chart for ATYR Performance & Benchmarks - 141% in 12m

Top Performer in Biotechnology

Short Term Performance

Symbol 1w 1m 3m
ATYR -19.4% -8.38% 40.7%
ABVX 8.20% 839% 941%
ABVX 7.37% 827% 843%
PROK -14.3% 399% 230%

Long Term Performance

Symbol 6m 12m 5y
ATYR 31.7% 141% 20.5%
RGC 0.0% 5,431% 4,594%
DRUG -9.72% 2,824% 24.6%
ABVX 1,111% 512% 520%

Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating

Symbol 1m 12m 5y P/E P/E Forward PEG EPS Stability EPS CAGR
GILD NASDAQ
Gilead Sciences
1.3% 52.7% 92.8% 23.8 14.3 0.24 13.8% 4.55%
UTHR NASDAQ
United Therapeutics
1.16% -10.2% 153% 11.2 10.9 1.43 72.0% 9.29%
AMGN NASDAQ
Amgen
2.19% -8.66% 40.3% 28.1 14.8 1.03 -30.1% 9.31%
NBIX NASDAQ
Neurocrine Biosciences
0.71% -15.8% 4.8% 43.5 26.5 0.27 -26.3% 15.4%
BIM PA
Biomerieux
5.8% 27.4% -7.28% 32.6 25.9 1.56 -45.1% -33.6%
PTCT NASDAQ
PTC Therapeutics
7.29% 59.5% 9.36% 7.57 5.51 0.81 - 88.6%
KMDA NASDAQ
Kamada
-6.96% 34.1% -17.7% 26.5 23.9 0.89 60.0% 40.6%
LONN SW
Lonza
1.42% 3.02% 1.21% 54.5 34.5 1.29 5.20% -7.55%

Performance Comparison: ATYR vs XBI vs S&P 500

XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ATYR
Total Return (including Dividends) ATYR XBI S&P 500
1 Month -8.38% 3.43% 0.66%
3 Months 40.72% 4.17% 11.66%
12 Months 141.03% -12.88% 15.92%
5 Years 20.51% -24.27% 103.09%

Trend Stabilty (consistency of price movement) ATYR XBI S&P 500
1 Month -8.9% -1.2% 66.4%
3 Months 72.7% 86.5% 96.6%
12 Months 79.3% -84.7% 50%
5 Years -48.8% -50.4% 84%

Relative Strength (compared with Indexes) Rank in Peer Group vs. XBI vs. S&P 500
1 Month 21 %th -11.42% -8.98%
3 Month 78 %th 35.09% 26.03%
12 Month 96 %th 176.67% 107.92%
5 Years 86 %th 59.13% -40.66%

FAQs

Does aTyr Pharma (ATYR) outperform the market?

Yes, over the last 12 months ATYR made 141.03%, while its related Sector, the SPDR S&P Biotech (XBI) made -12.88%. Over the last 3 months ATYR made 40.72%, while XBI made 4.17%.

Performance Comparison ATYR vs Indeces and Sectors

Above 0 means better perfomance compared to Symbol in this Timeframe

ATYR vs. Indices

Symbol 1w 1m 6m 12m
US S&P 500 SPY -17% -9% 27% 125%
US NASDAQ 100 QQQ -17.2% -9.6% 24.5% 120%
German DAX 40 DAX -16.1% -7.3% 22.8% 112%
Shanghai Shenzhen CSI 300 CSI 300 -16.8% -11.1% 22.7% 120%
Hongkong Hang Seng HSI -17.2% -10.5% 4.3% 102%
India NIFTY 50 INDA -17.4% -2.8% 28.1% 148%
Brasil Bovespa EWZ -18.3% -1% 24.7% 137%

ATYR vs. Sectors

Symbol 1w 1m 6m 12m
Communication Services XLC -18% -6.9% 27.7% 116%
Consumer Discretionary XLY -15.5% -7.4% 36.9% 122%
Consumer Staples XLP -17.7% -6.2% 29.3% 136%
Energy XLE -17.7% -8.5% 33% 144%
Financial XLF -15.6% -6% 30.7% 120%
Health Care XLV -15.5% -4.3% 41.9% 153%
Industrial XLI -16% -9.6% 21.7% 120%
Materials XLB -13.3% -4.7% 33.1% 145%
Real Estate XLRE -15.9% -7.4% 30.3% 139%
Technology XLK -17.5% -10.8% 18.4% 118%
Utilities XLU -20.9% -13.1% 20.5% 122%
Aerospace & Defense XAR -16.6% -12.5% 8.9% 95%
Biotech XBI -17.5% -11.8% 37.6% 154%
Homebuilder XHB -16.9% -9.6% 32.9% 150%
Retail XRT -14.6% -6.5% 32.4% 138%

ATYR vs. Commodities

Symbol 1w 1m 6m 12m
Oil USO -22.9% -13.2% 32.1% 140%
Natural Gas UNG -17.9% 1.5% 54.4% 137%
Gold GLD -19.9% -8.9% 12.7% 104%
Silver SLV -16.3% -11% 14.5% 112%
Copper CPER 3.7% 4.3% 30.1% 133%

ATYR vs. Bonds

Symbol 1w 1m 6m 12m
iShares 20+ Years Bond TLT -21% -8% 30.2% 145%
iShares High Yield Corp. Bond HYG -18.8% -8.1% 28.3% 133%